Reaction
Blood Bilirubin Unconjugated Increased reporting signals
As of the last recalculation, Blood Bilirubin Unconjugated Increased appears in 704 FAERS reports alongside 20 co-occurring drug terms. The strongest observed disproportionality signal is ATAZANAVIR (PRR 113.0).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Atazanavir | 51 | 113.0 | 113.4 |
| Ritonavir 100 Mg | 25 | 51.3 | 51.3 |
| Ritonavir | 42 | 45.1 | 45.2 |
| Lamivudine | 29 | 28.9 | 28.9 |
| Lamivudine Oral | 21 | 25.3 | 25.3 |
| Elexacaftor, Tezacaftor, And Ivacaftor | 10 | 24.0 | 24.1 |
| Busulfan | 12 | 22.9 | 22.9 |
| Nilotinib | 18 | 18.5 | 18.5 |
| Ado-Trastuzumab Emtansine | 5 | 17.7 | 17.7 |
| Ravulizumab | 7 | 15.5 | 15.5 |
| Entecavir | 6 | 15.3 | 15.3 |
| Dutasteride | 4 | 14.6 | 14.6 |
| Glecaprevir And Pibrentasvir | 5 | 13.5 | 13.5 |
| Ribavirin | 25 | 11.9 | 11.9 |
| Tenofovir Disoproxil Fumarate | 13 | 11.8 | 11.8 |
| Eltrombopag Olamine | 9 | 11.7 | 11.7 |
| Velpatasvir And Sofosbuvir | 4 | 9.3 | 9.3 |
| Sofosbuvir | 6 | 9.1 | 9.1 |
| Emtricitabine And Tenofovir Disoproxil Fumarate | 12 | 7.9 | 7.9 |
| Emtricitabine And Tenofovir Alafenamide | 3 | 7.9 | 7.9 |